✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Bharat Immunologicals & Biologicals Corporation Ltd.

BIBCL

Market Cap
₹105 Cr.
P/E
0.00

Bharat Immunologicals & Biologicals Corporation Ltd.

  • Bharat Immunological
  • Makers Laboratories
  • Achyut Healthcare
FAQs on Bharat Immunologicals & Biologicals Corporation Ltd. Shareprice

Bharat Immunological has given lower returns compared to its competitors.
Bharat Immunological has grown at ~-0.23% over the last 2yrs while peers have grown at a median rate of 6.9%

There is insufficient historical data to gauge this.
Latest PE of Bharat Immunological is 0

View FAQ's On Business
Growth Table
  • Bharat Immunologicals & Biologicals Corporation Ltd.
  • Makers Laboratories
  • Achyut Healthcare
Balance Sheet
  • Bharat Immunologicals & Biologicals Corporation Ltd.
  • Makers Laboratories
  • Achyut Healthcare
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Bharat Immunologicals & Biologicals Corporation Ltd.
  • Makers Laboratories
  • Achyut Healthcare
Cash Flow
  • Bharat Immunologicals & Biologicals Corporation Ltd.
  • Makers Laboratories
  • Achyut Healthcare
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Bharat Immunologicals & Biologicals Corporation Ltd.
  • Makers Laboratories
  • Achyut Healthcare
Quarterly Results
  • Bharat Immunologicals & Biologicals Corporation Ltd.
  • Makers Laboratories
  • Achyut Healthcare
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Bharat Immunologicals & Biologicals Corporation Ltd. Financials

Bharat Immunological balance sheet is weak and might have solvency issues

Yes, The debt of Bharat Immunological is increasing.
Latest debt of Bharat Immunological is ₹65.45 Crs as of Sep-23.
This is greater than Mar-23 when it was ₹52.75 Crs.

No, profit is decreasing.
The profit of Bharat Immunological is -₹17.27 Crs for TTM, -₹16.64 Crs for Mar 2023 and -₹8.75 Crs for Mar 2022.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bharat Immunological latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech